Indiana University Research and Technology Corp. personnel are marketing leading-edge inventions by IU researchers this week in Vancouver, British Columbia, Canada!
David Wilhite, Jennifer Finefield and Katherine Moynihan are meeting with business development executives at the Licensing Executives Society’s 2016 Annual Meeting through October 26. Some of those IU-discovered inventions include:
- Immunotherapy for acute leukemia created by Dr. Sophie Paczesny, IU School of Medicine.
- Predictive markers for diabetes created by Dr. Raghu G. Mirmira, IU School of Medicine.
- An RNAi-based larvacide for mosquitoes created by Molly Duman Scheel, IU School of Medicine-South Bend.
- A therapeutic for polycystic kidney disease created by Bonnie Blazer-Yost, School of Science at Indiana University-Purdue University Indianapolis.
Finefield, senior technology manager, said IU researchers across all academic disciplines are inventing new products and processes that can impact people’s lives.
“These inventors are doing more than conducting research for the sake of research. They are addressing the needs of people and industry around the world,” she said.
You can read more about IU technologies being marketed at the LES annual meeting here.
Leave a Reply